Ocular Hypertension Treatment Study (OHTS) commentary

Current Opinion in Ophthalmology

Volumn 14, Issue 2, 2003, Pages 74-77

  Lee, Brian L ^a   Wilson, M Roy ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glaucoma incidence; Glaucoma risk factors; Ocular hypertension; Primary open angle glaucoma

Indexed keywords

ANTIGLAUCOMA AGENT;

AGE DISTRIBUTION; CLINICAL TRIAL; CORNEA THICKNESS; HUMAN; INTRAOCULAR HYPERTENSION; OPEN ANGLE GLAUCOMA; OPTIC DISK CUP; PERIMETRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK FACTOR; TOPICAL TREATMENT; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ADMINISTRATION, TOPICAL; ADULT; AGED; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MULTICENTER STUDIES; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; VISUAL FIELDS;

EID: 0037564163     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200304000-00003     Document Type: Review

References (3)

1. Kass MA, Heuer DK, Higginbotham EJ, et al.: The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002, 120:701-713. This is the primary outcome paper from OHTS. The safety and efficacy of topical ocular hypertensive medication in delaying or preventing the onset of POAG are presented.
2. Gordon MO, Beiser JA, Brandt JD, et al.: The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002, 120:714-720. This is the companion paper to the primary outcome paper and it examines risk factors for converting from ocular hypertension to primary open-angle glaucoma.
3. Brandt JO, Beiser JA, Kass MA, et al. for The Ocular Hypertension Treatment Study (OHTS) Group: Central corneal thickness in the Ocular Hypertension Treatment Study. Ophthalmol 2001, 108:1779-1788.